Safety of therapeutic products used for hemophilia patients.
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission*; D006679:HIV Seropositivity / Q000453:epidemiology*; D006467:Hemophilia A / Q000628:therapy*; D002836:Hemophilia B / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000635:transmission*; D006358:Hot Temperature; D006801:Humans; D010949:Plasma; D011159:Population Surveillance; D012307:Risk Factors